Historic cancer waiting times: suspected cancer pathway collection, June 2019 to November 2021
Contents
| Data values | Data description | Date | local health board | tumour site |
|---|---|---|---|---|
| 349 | Number of new patients entering the pathway | Jun-19 | Betsi Cadwaladr | Head and neck |
| 766 | Number of new patients entering the pathway | Jun-19 | Betsi Cadwaladr | Upper GI |
| 631 | Number of new patients entering the pathway | Jun-19 | Betsi Cadwaladr | Lower GI |
| 140 | Number of new patients entering the pathway | Jun-19 | Betsi Cadwaladr | Lung |
| 0 | Number of new patients entering the pathway | Jun-19 | Betsi Cadwaladr | Sarcoma |
| 816 | Number of new patients entering the pathway | Jun-19 | Betsi Cadwaladr | Skin (exc BCC) |
| 5 | Number of new patients entering the pathway | Jun-19 | Betsi Cadwaladr | Brain/CNS |
| 672 | Number of new patients entering the pathway | Jun-19 | Betsi Cadwaladr | Breast |
| 419 | Number of new patients entering the pathway | Jun-19 | Betsi Cadwaladr | Gynaecological |
| 502 | Number of new patients entering the pathway | Jun-19 | Betsi Cadwaladr | Urological |
| 28 | Number of new patients entering the pathway | Jun-19 | Betsi Cadwaladr | Haematological (exc acute leukaemia) |
| 0 | Number of new patients entering the pathway | Jun-19 | Betsi Cadwaladr | Acute leukaemia |
| 1 | Number of new patients entering the pathway | Jun-19 | Betsi Cadwaladr | Childrens |
| 71 | Number of new patients entering the pathway | Jun-19 | Betsi Cadwaladr | Other |
| 4,400 | Number of new patients entering the pathway | Jun-19 | Betsi Cadwaladr | Total |
| 123 | Number of new patients entering the pathway | Jun-19 | Hywel Dda | Head and neck |
| 175 | Number of new patients entering the pathway | Jun-19 | Hywel Dda | Upper GI |
| 173 | Number of new patients entering the pathway | Jun-19 | Hywel Dda | Lower GI |
| 57 | Number of new patients entering the pathway | Jun-19 | Hywel Dda | Lung |
| 0 | Number of new patients entering the pathway | Jun-19 | Hywel Dda | Sarcoma |
| 310 | Number of new patients entering the pathway | Jun-19 | Hywel Dda | Skin (exc BCC) |
| 3 | Number of new patients entering the pathway | Jun-19 | Hywel Dda | Brain/CNS |
| 84 | Number of new patients entering the pathway | Jun-19 | Hywel Dda | Breast |
| 129 | Number of new patients entering the pathway | Jun-19 | Hywel Dda | Gynaecological |
| 167 | Number of new patients entering the pathway | Jun-19 | Hywel Dda | Urological |
| 13 | Number of new patients entering the pathway | Jun-19 | Hywel Dda | Haematological (exc acute leukaemia) |
| 2 | Number of new patients entering the pathway | Jun-19 | Hywel Dda | Acute leukaemia |
| 0 | Number of new patients entering the pathway | Jun-19 | Hywel Dda | Childrens |
| 116 | Number of new patients entering the pathway | Jun-19 | Hywel Dda | Other |
| 1,352 | Number of new patients entering the pathway | Jun-19 | Hywel Dda | Total |
| 191 | Number of new patients entering the pathway | Jun-19 | Swansea Bay | Head and neck |
| 44 | Number of new patients entering the pathway | Jun-19 | Swansea Bay | Upper GI |
| 181 | Number of new patients entering the pathway | Jun-19 | Swansea Bay | Lower GI |
| 64 | Number of new patients entering the pathway | Jun-19 | Swansea Bay | Lung |
| 41 | Number of new patients entering the pathway | Jun-19 | Swansea Bay | Sarcoma |
| 295 | Number of new patients entering the pathway | Jun-19 | Swansea Bay | Skin (exc BCC) |
| 0 | Number of new patients entering the pathway | Jun-19 | Swansea Bay | Brain/CNS |
| 163 | Number of new patients entering the pathway | Jun-19 | Swansea Bay | Breast |
| 162 | Number of new patients entering the pathway | Jun-19 | Swansea Bay | Gynaecological |
| 161 | Number of new patients entering the pathway | Jun-19 | Swansea Bay | Urological |
| 15 | Number of new patients entering the pathway | Jun-19 | Swansea Bay | Haematological (exc acute leukaemia) |
| 0 | Number of new patients entering the pathway | Jun-19 | Swansea Bay | Acute leukaemia |
| 1 | Number of new patients entering the pathway | Jun-19 | Swansea Bay | Childrens |
| 270 | Number of new patients entering the pathway | Jun-19 | Swansea Bay | Other |
| 1,588 | Number of new patients entering the pathway | Jun-19 | Swansea Bay | Total |
| 149 | Number of new patients entering the pathway | Jun-19 | Cardiff and Vale | Head and neck |
| 137 | Number of new patients entering the pathway | Jun-19 | Cardiff and Vale | Upper GI |
| 221 | Number of new patients entering the pathway | Jun-19 | Cardiff and Vale | Lower GI |
| 29 | Number of new patients entering the pathway | Jun-19 | Cardiff and Vale | Lung |
| 1 | Number of new patients entering the pathway | Jun-19 | Cardiff and Vale | Sarcoma |
| 327 | Number of new patients entering the pathway | Jun-19 | Cardiff and Vale | Skin (exc BCC) |
| 2 | Number of new patients entering the pathway | Jun-19 | Cardiff and Vale | Brain/CNS |
| 293 | Number of new patients entering the pathway | Jun-19 | Cardiff and Vale | Breast |
| 179 | Number of new patients entering the pathway | Jun-19 | Cardiff and Vale | Gynaecological |
| 184 | Number of new patients entering the pathway | Jun-19 | Cardiff and Vale | Urological |
| 19 | Number of new patients entering the pathway | Jun-19 | Cardiff and Vale | Haematological (exc acute leukaemia) |
| 1 | Number of new patients entering the pathway | Jun-19 | Cardiff and Vale | Acute leukaemia |
| 2 | Number of new patients entering the pathway | Jun-19 | Cardiff and Vale | Childrens |
| 1 | Number of new patients entering the pathway | Jun-19 | Cardiff and Vale | Other |
| 1,545 | Number of new patients entering the pathway | Jun-19 | Cardiff and Vale | Total |
| 224 | Number of new patients entering the pathway | Jun-19 | Cwm Taf Morgannwg | Head and neck |
| 123 | Number of new patients entering the pathway | Jun-19 | Cwm Taf Morgannwg | Upper GI |
| 332 | Number of new patients entering the pathway | Jun-19 | Cwm Taf Morgannwg | Lower GI |
| 76 | Number of new patients entering the pathway | Jun-19 | Cwm Taf Morgannwg | Lung |
| 0 | Number of new patients entering the pathway | Jun-19 | Cwm Taf Morgannwg | Sarcoma |
| 274 | Number of new patients entering the pathway | Jun-19 | Cwm Taf Morgannwg | Skin (exc BCC) |
| 0 | Number of new patients entering the pathway | Jun-19 | Cwm Taf Morgannwg | Brain/CNS |
| 206 | Number of new patients entering the pathway | Jun-19 | Cwm Taf Morgannwg | Breast |
| 223 | Number of new patients entering the pathway | Jun-19 | Cwm Taf Morgannwg | Gynaecological |
| 272 | Number of new patients entering the pathway | Jun-19 | Cwm Taf Morgannwg | Urological |
| 9 | Number of new patients entering the pathway | Jun-19 | Cwm Taf Morgannwg | Haematological (exc acute leukaemia) |
| 0 | Number of new patients entering the pathway | Jun-19 | Cwm Taf Morgannwg | Acute leukaemia |
| 1 | Number of new patients entering the pathway | Jun-19 | Cwm Taf Morgannwg | Childrens |
| 276 | Number of new patients entering the pathway | Jun-19 | Cwm Taf Morgannwg | Other |
| 2,016 | Number of new patients entering the pathway | Jun-19 | Cwm Taf Morgannwg | Total |
| 244 | Number of new patients entering the pathway | Jun-19 | Aneurin Bevan | Head and neck |
| 324 | Number of new patients entering the pathway | Jun-19 | Aneurin Bevan | Upper GI |
| 365 | Number of new patients entering the pathway | Jun-19 | Aneurin Bevan | Lower GI |
| 124 | Number of new patients entering the pathway | Jun-19 | Aneurin Bevan | Lung |
| 8 | Number of new patients entering the pathway | Jun-19 | Aneurin Bevan | Sarcoma |
| 453 | Number of new patients entering the pathway | Jun-19 | Aneurin Bevan | Skin (exc BCC) |
| 5 | Number of new patients entering the pathway | Jun-19 | Aneurin Bevan | Brain/CNS |
| 301 | Number of new patients entering the pathway | Jun-19 | Aneurin Bevan | Breast |
| 270 | Number of new patients entering the pathway | Jun-19 | Aneurin Bevan | Gynaecological |
| 364 | Number of new patients entering the pathway | Jun-19 | Aneurin Bevan | Urological |
| 22 | Number of new patients entering the pathway | Jun-19 | Aneurin Bevan | Haematological (exc acute leukaemia) |
| 0 | Number of new patients entering the pathway | Jun-19 | Aneurin Bevan | Acute leukaemia |
| 2 | Number of new patients entering the pathway | Jun-19 | Aneurin Bevan | Childrens |
| 17 | Number of new patients entering the pathway | Jun-19 | Aneurin Bevan | Other |
| 2,499 | Number of new patients entering the pathway | Jun-19 | Aneurin Bevan | Total |
| 5 | Number of new patients entering the pathway | Jun-19 | Powys | Head and neck |
| 0 | Number of new patients entering the pathway | Jun-19 | Powys | Upper GI |
| 0 | Number of new patients entering the pathway | Jun-19 | Powys | Lower GI |
| 0 | Number of new patients entering the pathway | Jun-19 | Powys | Lung |
| 0 | Number of new patients entering the pathway | Jun-19 | Powys | Sarcoma |
| 0 | Number of new patients entering the pathway | Jun-19 | Powys | Skin (exc BCC) |
| 0 | Number of new patients entering the pathway | Jun-19 | Powys | Brain/CNS |
| 0 | Number of new patients entering the pathway | Jun-19 | Powys | Breast |
| 6 | Number of new patients entering the pathway | Jun-19 | Powys | Gynaecological |
| 4 | Number of new patients entering the pathway | Jun-19 | Powys | Urological |
Main information
- Most recent update
- 23 October 2025
- Next update expected
- This dataset is not expected to be updated or replaced in the future
- Designation
- Official statistics in development
- Data provider
- Digital Health and Care Wales (DHCW)
- Data source
- Suspected Cancer Pathway (SCP)
Data notes
- Rounding applied
All percentages are rounded to one decimal place
Overview
- Summary of dataset and variables
Historical information on cancer waiting times, reported by local health boards, for those patients newly diagnosed with cancer who have started definitive treatment during the month.
The SCP starts at the point of suspicion (for example when a GP makes a referral) and this is when recorded waiting times start. Pathways are closed, and waiting times end, when patients start their first definitive treatment or are told they do not have cancer.
- Data collection or calculation
Historic suspected cancer pathway data was collected monthly on an aggregate basis from local health boards.
This collection has been succeeded by the new Suspected Cancer Pathway data collection, first published in February 2021.
Data does not include Welsh patients with cancer receiving treatment at private hospitals or at NHS hospitals outside Wales and only relates to patients newly diagnosed with cancer. A recurrence of the original primary cancer at a secondary site is not included within the data collection. However, if a patient has another primary cancer this will be included. The start of the cancer waiting time is the date upon which the decision to treat was confirmed between a designated member of the multi disciplinary team (MDT) and the patient.
- Statistical quality
Please find this information in the related statistical release, as per the given weblink.
These data are historical and no longer in development.
The SCP cancer services statistics were labelled as experimental from June 2019 to November 2022. Prior to this, cancer data were collected on the basis of urgent and non-urgent cancer pathways, and were designated as National Statistics. The SCP-based cancer statistics were designated as experimental because the method was new and subject to testing and ability to meet user needs.
A review in 2022 concluded that the methods were appropriate and the statistics were robust and reliable. They meet a range of key user needs and users regard them as credible, trustworthy and critical to their work. They were judged to be compliant with the key principles of the Code of Practice for official statistics and the experimental label was removed in November 2022. In February 2023 the Office for Statistics Regulation (OSR) agreed that the statistics meet the standards required for designation as National Statistics.
Published by
- Organisation
- Welsh Government
- Contact email
- stats.healthinfo@gov.wales